A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies

[1] Zeiger MA(2009)American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: Executive Summary of Recommendations Endocr Pract 99 125-127

[2] Thompson GB(2013)SAGES guidelines for minimally invasive treatment of adrenal pathology Surg Endosc 51 465-466

[3] Duh Q-Y(2017)European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma Br J Surg undefined undefined-undefined

[4] Hamrahian AH(2021)Outcomes of malignant pheochromocytoma based on operative approach: a National Cancer Database analysis Surgery undefined undefined-undefined

[5] Angelos P(2021)Implications of conversion during attempted minimally invasive adrenalectomy for adrenocortical carcinoma Ann Surg Oncol undefined undefined-undefined

[6] Elaraj D(2021)Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma J Surg Oncol undefined undefined-undefined

[7] Fishman E(2020)The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients’ stratification by body mass index and age BMC Endocr Disord undefined undefined-undefined

[8] Kharlip J(2017)Innovation in endocrine surgery: robotic versus laparoscopic adrenalectomy. Meta-analysis and systematic literature review Oncotarget undefined undefined-undefined

[9] Hamrahian AH(2016)Robotic assisted versus pure laparoscopic surgery of the adrenal glands: a case-control study comparing surgical techniques Langenbeck’s Arch Surg undefined undefined-undefined

[10] Garber JR(2013)Robotic versus laparoscopic adrenalectomy for pheochromocytoma Ann Surg Oncol undefined undefined-undefined

[1] Zeiger MA(2009)American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: Executive Summary of Recommendations Endocr Pract 99 125-127

[2] Thompson GB(2013)SAGES guidelines for minimally invasive treatment of adrenal pathology Surg Endosc 51 465-466

[3] Duh Q-Y(2017)European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma Br J Surg undefined undefined-undefined

[4] Hamrahian AH(2021)Outcomes of malignant pheochromocytoma based on operative approach: a National Cancer Database analysis Surgery undefined undefined-undefined

[5] Angelos P(2021)Implications of conversion during attempted minimally invasive adrenalectomy for adrenocortical carcinoma Ann Surg Oncol undefined undefined-undefined

[6] Elaraj D(2021)Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma J Surg Oncol undefined undefined-undefined

[7] Fishman E(2020)The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients’ stratification by body mass index and age BMC Endocr Disord undefined undefined-undefined

[8] Kharlip J(2017)Innovation in endocrine surgery: robotic versus laparoscopic adrenalectomy. Meta-analysis and systematic literature review Oncotarget undefined undefined-undefined

[9] Hamrahian AH(2016)Robotic assisted versus pure laparoscopic surgery of the adrenal glands: a case-control study comparing surgical techniques Langenbeck’s Arch Surg undefined undefined-undefined

[10] Garber JR(2013)Robotic versus laparoscopic adrenalectomy for pheochromocytoma Ann Surg Oncol undefined undefined-undefined